PLUS THERAPEUTICS, INC.·4

Feb 20, 5:30 PM ET

Sims Andrew John Hugh MacIntyre 4

4 · PLUS THERAPEUTICS, INC. · Filed Feb 20, 2025

Insider Transaction Report

Form 4
Period: 2025-02-18
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-18+60,02060,020 total
    Exercise: $1.18Exp: 2035-02-17Common Stock (60,020 underlying)
Footnotes (1)
  • [F1](1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4